Bone Remodeling Around a Trabecular Titanium Cup in Total Hip Arthroplasty
ConditionTotal Hip Arthroplasty
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-85
SponsorPermedica spa
About this trial
The goal of this randomized controlled trial is to measure the periprosthetic bone mineral density changes around a 3D-printed highly-porous titanium acetabular cup used in primary total hip arthroplasty compared to a standard hydroxyapatite/titanium plasma-sprayed acetabular cup up to 2-year follow-up.
Eligibility criteria
Qualifiers
Patient candidated to undergo unilateral cementless primary total hip arthroplasty with Jump System Traser® cup or Jump System HAX-Pore® cup by Permedica Orthopaedics (study sponsor).
Patient with primary or secondary hip osteoarthritis;
Patient who has given informed consent;
Disqualifiers
Male patients younger than 40 years or older than 85 years;
Female patients younger than 50 years or older than 85 years;
Childbearing;
Patients not indicated for receiving the investigational devices;
Trial design
Treatments tested in this trial
- Jump System Traser® cup
- Jump System HAX-Pore® cup
Treatment groups
50 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov